Полиморфизм генов CYP11а1, CYP17, CYP19 у женщин репродуктивного возраста с синдромом поликистозных яичников

1. Назаренко Т.А., Мишиева Н.Г. Бесплодие и возраст: пути решения проб­лемы. 2-е изд. М.: МЕДпресс-информ; 2014: 216–20.

2. Lizneva D., Suturina L., Walker W., Brakta S., Gavrilova-Jordan L., Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 2016; 106(1): 6–15. https://dx.doi.org/10.1016/j.fertnstert.2016.05.003.
3. Joham A.E., Teede H.J., Ranasinha S., Zoungas S., Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J. Womens Health (Larchmt). 2015; 24(4): 299–307. https://dx.doi.org/10.1089/jwh.2014.5000.
4. Joseph S., Barai R.S., Bhujbalrao R., Idicula-Thomas S. PCOSKB: A KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with Polyсystic Ovary Syndrome. Nucleic Acids Res. 2015; 44(D1): D1032-5. https://dx.doi.org/10.1093/nar/gkv1146.
5. Azziz R., Carmina E., Chen Z., Dunaif A., Laven J.S., Legro R.S. et al. Polycystic ovary syndrome. Nat. Rev. Dis. Primers. 2016; 2: 16057. https://dx.doi.org/10.1038/nrdp.2016.57.

6. Найдукова А.А., Каприна Е.К., Донников А.Е., Чернуха Г.Е. Генетические аспекты формирования синдрома поликистозных яичников. Акушерство и гинекология. 2016; 3: 16–22. https://dx.doi.org/10.18565/aig.2016.3.16–22.

7. Ibanez L., Oberfield Sh.E., Witchel S.F., Auchus R.J., Chang R.J., Codner E. et al. An international consortium apdate: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm. Res. Paediatr. 2017; 88(6): 371–95. https://dx.doi.org/10.1159/000479371.
8. Day F.R., Hinds D.A., Tung J.Y., Stolk L., Styrkarsdottir U., Saxena R. et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat. Commun. 2015; 6: 8464. https://dx.doi.org/10.1038/ncomms9464.
9. Reddy K.R., Deepika M.L., Supriya K., Latha K.P., Rao S.S., Rani V.U., Jahan P. CYP11A1 microsatellite (tttta)n polymorphism in PCOS women from South India. J. Assist. Reprod. Genet. 2014; 31(7): 857–63. https://dx.doi.org/10.1007/s10815-014-0236-x.
10. Kaur R., Kaur T., Kaur A. Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome. J. Assist. Reprod. Genet. 2018; 35(6): 1123–9. https://dx.doi.org/10.1007/s10815-018-1162-0.

11. Дубровина С.О. Синдром поликистозных яичников: современный обзор. Гинекология. 2016; 18(5): 14–7.

12. Адамян Л.В., Андреева Е.Н., Гаспарян С.А., Геворкян М.А., Григорян О.Р., Гриняева Е.Н., Густовалова Е.А., Дедов И.И., Демидова Т.Ю., Карахалис М.Ю., Лизиева Л.Е., Спиридонова Н.Е., Сутурина Л.В., Тарасова М.А., Уварова Е.В., Филиппов О.С., Хамошина М.С., Чернуха Г.Е., Шереметьева Е.В., Ярмолинская М.В., Соболева Е.Л., Ярмолинская М.И. Синдром поликистозных яичников в репродуктивном возрасте (со­временные подходы к диагностике и лечению). Клинические рекомендации (протокол лечения). М.; 2015. Доступно по: https://kuzdrav.ru/special/guideline/cragmz.php?PAGEN_1=3

13. Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin. Endocrinol. 2018; 89(3): 251–68. https://dx.doi.org/10.1111/cen13795.
14. Akgul S., Derman O., Alikaşifoglu M., Aktaş D. CYP1A1 polymorphism in adolescents with polycystic ovary syndrome. Int. J. Gynaecol. Obstet. 2011; 112(1): 8–10. https://dx.doi.org/10.1016/j.ijgo.2010.07.032.
15. Chua A.K., Azziz R., Goodarzi M.O. Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage. Mol. Hum. Reprod. 2012; 18(6): 320–4. https://dx.doi.org/10.1093/molehr/gas002.
16. Diamanti-Kandarakis E., Bartzis M.I., Zapanti E.D., Spina G.G., Filandra F.A., Tsianateli T.C. et al. Polymorphism T→ C (− 34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil. Steril. 1999; 71(3): 431–5. https://dx.doi.org/10.1016/s0015-0282(98)00512-3.
17. Echiburú B., Pérez-Bravo F., Maliqueo M., Sánchez F., Crisosto N., Sir-Petermann T.Polymorphism T –> C (−34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study. Metabolism. 2008; 57(12): 1765–71. https://dx.doi.org/10.1016/j.metabol.2008.08.002.
18. Park J., Lee E., Ramakrishna S., Cha D., Baek K. Association study for single nucleotide polymorphisms in the CYP17A1 gene and polycystic ovary syndrome. Int. J. Mol. Med. 2008; 22(2): 249–54.
19. Unsal T., Konac E., Yesilkaya E., Yilmaz A., Bideci A., Ilke O.H. et al. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. J. Assist. Reprod. Genet. 2009; 26(4): 205–16. https://dx.doi.org/10.1007/s10815-009-9308-8.
20. Jin J.L, Sun J., Ge H.J., Cao Y.X., Wu X.K., Liang F.J. et al. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. BMC Med. Genet. 2009; 10: 139. https://dx.doi.org/10.1186/1471-2350-10-139.
21. Gharani N., Waterworth D.M., Batty S. Association of the steroid synthesis gene CYP11A with PCOS and hyperandrogenism. Hum. Mol. Genet. 1997; 6(3): 397–402. https://dx.doi.org/10.1093/hmg/6.3.397.

Поступила 31.05.2019

Принята в печать 21.06.2109